Short Interest in Sartorius (OTCMKTS:SARTF) Decreases By 49.9%

Sartorius (OTCMKTS:SARTF) saw a significant drop in short interest during the month of July. As of July 31st, there was short interest totaling 458 shares, a drop of 49.9% from the July 15th total of 915 shares. Currently, 0.0% of the company’s shares are short sold. Based on an average daily volume of 0 shares, the days-to-cover ratio is currently ∞ days.

Sartorius Stock Performance

OTCMKTS SARTF opened at $212.80 on Tuesday. Sartorius has a fifty-two week low of $181.58 and a fifty-two week high of $227.00. The company has a debt-to-equity ratio of 0.89, a quick ratio of 0.49 and a current ratio of 0.95. The stock has a 50 day simple moving average of $211.73 and a two-hundred day simple moving average of $218.48. The stock has a market cap of $7.28 billion, a P/E ratio of 98.98 and a beta of 0.98.

About Sartorius

Sartorius AG, trading in the U.S. over the counter under the symbol SARTF, is a Germany-based provider of laboratory and bioprocessing equipment for the pharmaceutical, biotechnology and research industries. The company is organized into two core divisions: Bioprocess Solutions, which focuses on single-use consumables, filtration technologies and upstream and downstream processing systems; and Lab Products & Services, which supplies laboratory instruments, consumables and services, including balances, pipettes, cell counting systems and water purification units.

The Bioprocess Solutions segment serves customers engaged in the development and manufacture of biopharmaceuticals, vaccines and advanced therapies.